N. Hribernik, R. Arko, G. Gasljevic, and M. Reberšek, “Adjuvant nivolumab in resected oesophageal or gastroesophageal junction cancer following neoadjuvant chemoradiotherapy: Slove-nian real-world data”, Radiol Oncol, vol. 60, no. 2, pp. 288–293, Jul. 2026.